Longeveron (LGVN) Revenue & Revenue Breakdown
Longeveron Revenue Highlights
Latest Revenue (Y)
$709.00K
Latest Revenue (Q)
$548.00K
Longeveron Revenue by Period
Longeveron Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $709.00K | -41.98% |
| 2022-12-31 | $1.22M | -6.43% |
| 2021-12-31 | $1.31M | -76.80% |
| 2020-12-31 | $5.63M | -0.18% |
| 2019-12-31 | $5.64M | 164.17% |
| 2018-12-31 | $2.13M | - |
Longeveron generated $709.00K in revenue during NA 2023, up -41.98% compared to the previous quarter, and up 33.21% compared to the same period a year ago.
Longeveron Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $548.00K | 769.84% |
| 2023-12-31 | $63.00K | -58.00% |
| 2023-09-30 | $150.00K | -30.88% |
| 2023-06-30 | $217.00K | -22.22% |
| 2023-03-31 | $279.00K | 130.58% |
| 2022-12-31 | $121.00K | -54.34% |
| 2022-09-30 | $265.00K | -43.13% |
| 2022-06-30 | $466.00K | 25.95% |
| 2022-03-31 | $370.00K | 77.03% |
| 2021-12-31 | $209.00K | -9.91% |
| 2021-09-30 | $232.00K | -52.56% |
| 2021-06-30 | $489.00K | 30.05% |
| 2021-03-31 | $376.00K | -68.13% |
| 2020-12-31 | $1.18M | -36.74% |
| 2020-09-30 | $1.86M | 112.90% |
| 2020-06-30 | $876.00K | -48.71% |
| 2020-03-31 | $1.71M | -7.34% |
| 2019-12-31 | $1.84M | - |
Longeveron generated $548.00K in revenue during Q1 2024, up 769.84% compared to the previous quarter, and up 452.89% compared to the same period a year ago.
Longeveron Revenue Breakdown
Longeveron Revenue Breakdown by Product
Quarterly Revenue by Product
| Product/Service | Mar 21 |
|---|---|
| ClinicalTrialRevenueMember | $165.00K |
| AlzheimersAssociationGrantMember | $170.00K |
| MarylandTEDCOGrantMember | $41.00K |
Longeveron's latest quarterly revenue breakdown by segment (product or service), as of Mar 21: AlzheimersAssociationGrantMember (45.21%), ClinicalTrialRevenueMember (43.88%), and MarylandTEDCOGrantMember (10.90%).
Longeveron Revenue Breakdown by Country
Quarterly Revenue by Country
| Country | Mar 21 |
|---|---|
| MarylandTEDCOGrantMember | $41.00K |
| AlzheimersAssociationGrantMember | $170.00K |
| ClinicalTrialRevenueMember | $165.00K |
Longeveron's latest quarterly revenue breakdown by geography, as of Mar 21: AlzheimersAssociationGrantMember (45.21%), ClinicalTrialRevenueMember (43.88%), and MarylandTEDCOGrantMember (10.90%).
Longeveron Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| BOLT | Bolt Biotherapeutics | $7.88M | $1.27M |
| KZR | Kezar Life Sciences | $7.00M | - |
| KRON | Kronos Bio | $6.29M | $2.69M |
| GBIO | Generation Bio | $5.90M | $4.06M |
| NTRB | Nutriband | $2.09M | $442.83K |
| LGVN | Longeveron | $709.00K | $548.00K |
| ABVC | ABVC BioPharma | $152.43K | $117.14K |
| KROS | Keros Therapeutics | $151.00K | $83.00K |
| VRAX | Virax Biolabs Group | $8.56K | $76.50K |
| FBRX | Forte Biosciences | - | - |
| CCCC | C4 Therapeutics | - | - |
| REVB | Revelation Biosciences | - | - |
| HILS | Tharimmune | - | - |
| ERAS | Erasca | - | - |
| RNXT | RenovoRx | - | - |
| LRMR | Larimar Therapeutics | - | - |
| INDP | Indaptus Therapeutics | - | - |
| EWTX | Edgewise Therapeutics | - | - |
| SRZN | Surrozen | - | - |
| QNRX | Quoin Pharmaceuticals | - | - |
| KPRX | Kiora Pharmaceuticals | - | $20.00K |
| BWV | Onconetix | - | - |
| KTTA | Pasithea Therapeutics | - | - |
LGVN Revenue FAQ
What is Longeveron’s yearly revenue?
Longeveron's yearly revenue for 2023 was $709K, representing a decrease of -41.98% compared to 2022. The company's yearly revenue for 2022 was $1.22M, representing a decrease of -6.43% compared to 2021. LGVN's yearly revenue for 2021 was $1.31M, representing a decrease of -76.80% compared to 2020.
What is Longeveron’s quarterly revenue?
Longeveron's quarterly revenue for Q1 2024 was $548K, a 769.84% increase from the previous quarter (Q4 2023), and a 96.42% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $63K, a -58.00% decrease from the previous quarter (Q3 2023), and a -47.93% decrease year-over-year (Q4 2022). LGVN's quarterly revenue for Q3 2023 was $150K, a -30.88% decrease from the previous quarter (Q2 2023), and a -43.40% decrease year-over-year (Q3 2022).
What is Longeveron’s revenue growth rate?
Longeveron's revenue growth rate for the last 3 years (2021-2023) was -45.71%, and for the last 5 years (2019-2023) was -87.43%.